Association of Growth and Differentiation Factor 15 in Rheumatoid Arthritis
Yan-Wei He,Cheng-Song He
DOI: https://doi.org/10.2147/JIR.S350281
IF: 4.5
2022-02-19
Journal of Inflammation Research
Abstract:Yan-Wei He, 1 Cheng-Song He 2 1 Department of Orthopaedics, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China; 2 Department of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China Correspondence: Cheng-Song He, Department of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China, Email Purpose: Rheumatoid arthritis (RA) is an inflammatory rheumatic disease, which has been demonstrated to correlate with mutated genetics. Growth and differentiation factor 15 (GDF-15) is a member of the transforming growth factor-β superfamily and is expressed in different organs, tissues and immune cells. To date, limited studies have evaluated plasma levels of GDF-15 in RA patients, and whether GDF-15 gene polymorphisms correlate with RA risk in the Chinese Han population has not been clarified. Patients and Methods: This case-control study recruited 910 age- and sex-matched RA patients and healthy controls. Plasma levels of GDF-15 were examined by enzyme linked immunosorbent assay, and polymorphisms (rs1055150, rs1058587, rs3787023, and rs4808793) were genotyped by KASP method. Results: RA patients had higher levels of GDF-15 as compared to that in healthy controls. Patients with positive CRP also showed higher levels of GDF-15 when compared to that in patients with negative CRP. Levels of GDF-15 correlated with disease activity score. Frequencies of GG, GC, GG+GC genotypes and G allele in GDF-15 gene rs1058587 were significantly elevated in RA patients compared to controls. Frequencies of CC genotype and C allele in GDF-15 gene rs3787023 were higher in RA patients compared to controls. Other polymorphisms did not correlate with RA susceptibility. Moreover, the four polymorphisms were not correlated with levels of GDF-15. Conclusion: Plasma levels of GDF-15 were elevated in RA patients and GDF-15 gene polymorphisms were related to RA risk in the Chinese Han population. Keywords: rheumatoid arthritis, growth and differentiation factor 15, polymorphism, pathogenesis Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. 1 This disease is characterized by large autoantibodies production, paired with tender and swollen joints. To date, the clear pathogenesis of RA has not been clarified. However, inflammatory cytokines genetics have been widely discussed and are accepted to play significant roles in the development of this complex disorder. 2 Growth and differentiation factor 15 (GDF-15) belongs to the transforming growth factor-β (TGF-β) superfamily and was first identified in 1997. 3 This superfamily has more than 30 members. GDF-15 circulates as a ~25 kDa homodimer comprising two 112 amino acid polypeptide chains. 4 Human GDF-15 gene locates at chromosome 19p12.1–13.1. GDF-15 expresses at different organs or tissues, such as the placenta, kidney, or lung, and different immune cells express GDF-15, such as the macrophage or T-cell. 5 Several studies have discussed GDF-15 gene polymorphisms with human diseases. 6–8 For example, carriers of the GC genotype in rs1058587 polymorphism had a lower risk of sporadic prostate cancer and of familial prostate cancer than the CC genotype carriers. 8 There was a strong association between serum levels of GDF-15 and neoplastic progression, and determination of GDF-15 gene rs1058587 genotypes may have clinical usage in management of colorectal carcinoma patients. 7 Recently, studies have shown that serum levels of GDF-15 were higher in RA patients, correlating with disease activity. However, whether plasma levels of GDF-15 were abnormal in RA patients needs to be clarified. In addition, whether GDF-15 gene polymorphisms were related to RA risk in the Chinese Han population needs to be discussed. This study recruited 455 RA patients and 455 healthy controls from the department of Rheumatology and Immunology, department of Orthopaedics, affiliated hospital of Southwest Medical University. RA patients were diagnosed according to the American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) classification criteria. 9 RA patients were either newly diagnosed without any treatment or had been diagnosed before but had not used any medication in the last 3 months. Healthy controls were recruited from the Health Management Center in the affiliated hospital of Southwest Medical University. RA patients are of Chinese Han origin. Among the patients, 112 were male and 343 were female, while there were 116 male and 339 female healthy cont -Abstract Truncated-
immunology